Taysha Gene Therapies (TSHA) Q2 2025 Earnings

15MayConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.16
-0.13
-0.1
-0.07

Details

Expected EPS
-0.087608
Actual EPS
-0.08
Surprise EPS
0.01
Surprise Percent
+8.68%

Description

Taysha Gene Therapies (TSHA) has reported earnings of -0.08 per share for Q2 2025.

0 Comments

Share your thoughts